comparemela.com

Latest Breaking News On - Boehringer ingelheim eli lilly - Page 1 : comparemela.com

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.

Boston
Massachusetts
United-states
New-york
Parag-goyal
Varun-sundaram
Jacob-joseph
Mary-norine-walsh
Boehringer-ingelheim-eli-lilly
Veterans-health-administration
National-death-index
Case-western-reserve-university-school-of-medicine

Early Empagliflozin Doesn't Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

(UPDATED) Neutral findings for another SGLT2 inhibitor, after the “soft” success of DAPA-MI, are a rare disappointment for this class.

Australia
Uppsala
Uppsala-lan
Sweden
Dallas
Texas
United-states
Boston
Massachusetts
Sydney
New-south-wales
Javed-butler

Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI

Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Boston
Bykatie-kalvaitis
Javed-butler
Baylor-scott
Jamesl-januzzi
Boehringer-ingelheim-eli-lilly
Erik-swain
Patrickt-ogara
Baim-institute-for-clinical-research
White-research-institute

More competition, access could reduce prices for diabetes therapies

More competition, access could reduce prices for diabetes therapies
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Ozempic-rybelsus
Bymichael-monostra
Richard-smith
Boehringer-ingelheim-eli-lilly
Eli-lilly
Novo-nordisk
Astrazeneca
Yale-school-of-medicine
South-america
Central-america

What's Going to Be Hot at ACC 2024

Some eagerly awaited drug and device trials, like RELIEVE-HF and EMPACT-MI, will be unveiled at the ACC’s 75th annual meeting.

United-states
Boston
Massachusetts
American
Boehringer-ingelheim-eli-lilly
Douglas-drachman
Katie-berlacher
Imbria-pharmaceuticals
Md-university-of-pittsburgh
Astrazeneca
American-college-of-cardiology
Beth-israel-deaconess-medical-center

vimarsana © 2020. All Rights Reserved.